Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Natural Blood and Blood Product Toxicity”

2 trials

Showing 2 of 2 results

Early research (Phase 1)Not Yet RecruitingNCT06919861
What this trial is testing

Pharmacokinetics, Pharmacodynamics, and Safety of Nanokine Produced by Nanogen Pharmaceutical Joint Stock Company

Who this might be right for
Natural Blood and Blood Product Toxicity
Nanogen Pharmaceutical Biotechnology Joint Stock Company 44
Testing effectiveness (Phase 2)Study completedNCT05585658
What this trial is testing

A Randomized, Double-blinded, Active Controlled Crossover Clinical Trial to Investigate PK, PD and Safety of GBPD002

Who this might be right for
Natural Blood and Blood Product Toxicity
Globe Biotech Limited 42

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation